| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |